Research

Join Professor Paul Bannon, and Dr Robert Hume as they discuss their ground-breaking research. In this webinar, you will be provided with an overview of their research into novel degradable blood vessel replacements at the Centre for Heart Failure and Diseases of the Aorta. Exciting preliminary results have shown that our new elastic and degradable artery replacements have reduced thromboses (blockages), when compared to the synthetic replacements currently used in surgery.  Additionally, our artery replacements have begun to change in size, to a shape that fits more closely with the healthy artery above and below it.

Thanks to the generous support of our donors, we will be able to use cutting edge technology,  called spatial transcriptomics, to interrogate each individual cell that has grown into the artery replacements and investigate how closely their gene expression (mRNA) mimics that of a healthy artery.

Join Professor John O’Sullivan and Associate Professor Sean Lal as they discuss their ground-breaking research. In this webinar, you will be provided with an overview of how we plan to study potential therapeutic treatments to reverse heart failure. Heart failure is a global health problem with a mortality rate of up to 75% within 5 years of diagnosis.

We discuss The Baird Institute’s world-first trial in humans (the CardioNAD clinical trial) that aims to provide the heart with the fuel it needs to improve its energy utilisation and hence reverse heart failure. We also discuss our strategies to make new heart cells (ie. cardiac regeneration) which can improve heart function after a heart attack.

Thanks to the generous support of our donors, we will be able to purchase much needed materials to conduct the analytical aspects of our study which in turn will assist us to achieve our ultimate goal of developing a new therapy for patients with heart failure.